发明名称 DILTIAZEM CONTROLLED RELEASE FORMULATION AND METHOD OF MANUFACTURE
摘要 A controlled release diltiazem dosage formulation comprising a plurality of diltiazem pellets and a gel-forming material where the time of maximum diltiazem blood plasma levels occurs more than 8 hours after administration and preferably more than 10 hours after administration.
申请公布号 EP1912631(A2) 申请公布日期 2008.04.23
申请号 EP20060801043 申请日期 2006.08.10
申请人 WATSON PHARMACEUTICALS, INC. 发明人 CHENG, XUI, XUI;QI, XIAOHONG;ZHANG, GUOHUA;DIXIT, MANESH
分类号 A61K9/50;A61K9/20;A61K9/26;A61K31/554 主分类号 A61K9/50
代理机构 代理人
主权项
地址